First-Time Seizures Signal Hidden Cancer Risk Beyond the Brain
A 50,000-patient Danish study finds first-time seizures raise cancer risk 5x in year one, including non-neurologic cancers like lung and colorectal.
Summary
A large Danish study of nearly 50,000 adults found that experiencing a first-time seizure significantly raises the risk of being diagnosed with cancer within the following year — and beyond. The overall cancer risk was five times higher than the general population in the first year, with a 4.1% absolute risk. Importantly, the elevated risk wasn't limited to brain tumors. Non-neurologic cancers, including lung and colorectal cancer, were also more common. Researchers suggest seizures may serve as an early warning sign of hidden or metastatic cancer. Published in JAMA Neurology, the findings support more thorough cancer screening following a first-time seizure event.
Detailed Summary
A first-time seizure may be more than a neurological event — it could be an early signal of undetected cancer anywhere in the body. This finding, published in JAMA Neurology, comes from one of the largest population-based studies ever conducted on this question, drawing on Danish medical registry data spanning nearly three decades.
Researchers followed 49,894 adults who experienced a first-time seizure between 1996 and 2022. Within the first year, 4.1% were diagnosed with cancer — a standardized incidence ratio of 5.30 compared to the general population. Neurologic cancers showed a dramatically elevated risk (SIR 76.1), but non-neurologic cancers were also significantly elevated (SIR 2.32), with lung and colorectal cancers among the most common.
The practical implication is striking: for every 30 people presenting with a first-time seizure, one additional cancer case would be detected through systematic screening. That number rises to 103 for non-neurologic cancers specifically — still a clinically meaningful signal.
Risks didn't disappear after the first year. Absolute cancer risk remained at 3.5% between years one and five, and climbed to 13.4% over a 5-to-20-year window. This long-term elevation suggests seizures may reflect underlying biological vulnerabilities — not just acute tumor effects.
For health-conscious adults, this research reinforces the importance of treating unexplained neurological symptoms as potential systemic red flags. A first-time seizure in a middle-aged adult (median age in this study was 51.5) warrants comprehensive evaluation, not just neurological workup. Clinicians may need to expand cancer screening protocols following seizure presentations. Caveats include the observational design and the Danish population's demographic specificity, which may limit global generalizability.
Key Findings
- First-time seizures linked to 5x higher overall cancer risk within one year versus general population.
- Non-neurologic cancers like lung and colorectal were 2.32x more likely after a first seizure.
- One additional cancer detected for every 30 seizure patients screened in year one.
- Elevated cancer risk persists long-term: 13.4% absolute risk over 5–20 years post-seizure.
- Seizures may serve as early clinical markers of metastatic or advanced hidden cancer.
Methodology
This is a news report summarizing a peer-reviewed cohort study published in JAMA Neurology, a high-credibility journal. The evidence basis is a large observational registry study of 49,894 adults using Danish nationwide medical data from 1996–2022. Observational design limits causal inference but the sample size and long follow-up period strengthen reliability.
Study Limitations
The study is observational and cannot establish causation between seizures and cancer. Findings are drawn from a Danish population, which may not fully generalize to other ethnic or healthcare demographics. The article is a news summary; readers should consult the full JAMA Neurology paper for complete methodology and subgroup data.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.